Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.71% | 30.26 | 14.1% | $178.05m | |
| AMRN | Amarin Corp. Plc | -0.75% | 19.91 | 1.7% | $159.55m | |
| AXSM | Axsome Therapeutics, Inc. | -2.31% | 90.34 | 1.9% | $129.63m | |
| SAVA | Cassava Sciences, Inc. | -4.40% | 8.25 | 0.0% | $91.12m | |
| ARQL | ArQule, Inc. | 0.15% | 20.00 | 0.6% | $78.96m | |
| BHC | Bausch Health Cos., Inc. | 1.71% | 30.26 | 0.0% | $74.96m | |
| SAGE | SAGE Therapeutics, Inc. | 3.12% | 76.40 | 8.6% | $70.78m | |
| GWPH | GW Pharmaceuticals Plc | -0.13% | 118.97 | 6.2% | $70.43m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.36% | 151.05 | 2.3% | $67.88m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.76% | 106.11 | 16.9% | $63.50m | |
| PRGO | Perrigo Co. Plc | -0.82% | 59.02 | 6.8% | $58.61m | |
| HZNP | Horizon Therapeutics Plc | 0.29% | 38.40 | 6.6% | $57.70m | |
| ENDP | Endo International Plc | -2.27% | 6.04 | 8.8% | $42.46m | |
| ICLR | ICON plc | 0.38% | 175.78 | 4.2% | $41.39m | |
| CTLT | Catalent, Inc. | -1.03% | 60.84 | 2.4% | $37.19m |
Company Profile
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.